Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma

Journal of enzyme inhibition and medicinal chemistry, 2023-12, Vol.38 (1), p.2201408-2201408 [Peer Reviewed Journal]

2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023 ;2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023 The Author(s) ;ISSN: 1475-6366 ;EISSN: 1475-6374 ;DOI: 10.1080/14756366.2023.2201408 ;PMID: 37096557

Full text available